The Department of Pathology at Beth Israel Deaconess Medical Center (BIDMC) is recruiting a full-time academic hematopathologist. BIDMC is a tertiary care facility with 743 licensed beds and an internationally renowned principal teaching hospital of Harvard Medical School with NCI Comprehensive Cancer Center-affiliated Cancer Center with strong and growing focus on hematologic malignancies.

 

The BIDMC Department of Pathology has launched new strategic Initiatives in cutting-edge Precision Diagnostics (including cancer genomics, multiplex biomarker theranostics, and computational/digital pathology). In addition, the department will be engaged in the newly announced and exciting clinical collaboration between Dana-Farber Cancer Institute, BIDMC, and Harvard Medical Faculty Physicians (HMFP) to establish New England’s only free-standing adult inpatient cancer hospital. The collaboration would bring together world-class clinicians to deliver transformational, precision medicine in an environment solely dedicated to defying cancer.

 

We are looking for an active, energetic, team-oriented faculty member to help us actively shape our future agenda and to take leadership in areas that are being actively developed.

 

In addition to strong hematopathology diagnostic skills, expertise in advanced flow cytometry, molecular diagnostics (including NGS and FISH) are desirable. Strong interest in further developing the crucial role of Pathology in clinical trials is a plus, including new companion diagnostics.

 

Candidates with a strong clinical, translational, or laboratory-based research program are particularly encouraged to apply. Candidates with existing NIH grant funding will be supported by attractive research space and start-up funds to expand their programs.

 

The successful candidate will join a team of hematopathologists, cytogeneticists, and molecular diagnosticians, residents, and fellows to provide world-class diagnostics for benign and malignant hematology, stem cell transplantation, and the cancer vaccine and T-cell therapies center at BIDMC.

 

Applicants must be board certified in Pathology (AP or AP/CP) and Hematopathology.Board certification in Molecular Pathology (including NGS experience) is a significant plus.

 

The candidate will be appointed to the full-time faculty of Harvard Medical School at an academic rank commensurate with experience.

 

Research:

 

Beth Israel Deaconess Medical Center consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. Research funding totals over $229.8 million annually. BIDMC researchers run more than 850 active sponsored projects and 500 funded and non-funded clinical trials.

 

The Harvard-Thorndike Laboratory, the nation's oldest clinical research laboratory, has been located on this site since 1973. BIDMC also shares important clinical and research programs with institutions such as the Dana-Farber/Harvard Cancer Center (DFCI), Joslin Diabetes Center and Children's Hospital.

 

BIDMC is part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, and 38,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.

 

Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP) is one of the largest physician organizations in New England, dedicated to excellence and innovation in patient care, education, and research. As a physician-led organization, HMFP partners with more than 2,200 providers to support the delivery of exceptional care, promote professional development and diversity, and foster balance at work and home. HMFP physicians have faculty affiliations with Harvard Medical School (HMS) and provide care throughout the Beth Israel Lahey Health (BILH) system and additional hospitals across Massachusetts.

 

For further questions or confidential position inquiries, please contact Dr. Lynne Uhl, Vice Chair of Clinical Pathology at BIDMC:  luhl@bidmc.harvard.edu